After surviving a benign brain tumor, actress and journalist Maria Menounos announced a stage 2 pancreatic cancer diagnosis while expecting a baby.
Actress, journalist and former “E! News” correspondent Maria Menounos announced that she was diagnosed and treated for stage 2 pancreatic cancer in January 2023.
The 44-year-old is expecting a daughter via surrogate, along with her husband Keven Undergaro. The cancer diagnosis was preceded by a diagnosis of type 1 diabetes, which she quickly got under control. However, after a few months, Menounos began experiencing intense abdominal pain. A friend recommended that she undergo a full-body MRI, which revealed a mass, and a biopsy later revealed that she had stage 2 pancreatic cancer.
The 5-year relative survival rates for pancreatic cancer remain low, but improve dramatically when the disease is caught in its early stages. When localized to the pancreas, the 5-year survival rate is 44%, according to the National Cancer Institute. Pancreas cancer is difficult to detect in its early stages, with more than 80% diagnosed when advanced, according to Johns Hopkins. The onset of diabetes, along with other signs and symptoms, is a precursor of pancreatic cancer.
Soon after her diagnosis, Menounos underwent surgery to remove part of her pancreas, the entire spleen, 17 lymph nodes and a fibroid “the size of a baby” on her uterus.
“All that kept flashing through my head was my baby,” Menounos said in an emotional interview with “TODAY.” “I was like, ‘Oh my God. I can’t believe this is going to happen to me.”
This was not the first health complication Menounos faced. In 2017, she underwent surgery for a benign brain tumor. Later that year, she was also the keynote speaker for CURE®’s third annual GBM Heroes event, honoring individuals who made a difference in the lives of patients with glioblastoma multiforme, an aggressive form of brain cancer.
Now, Menounos said that she is cancer-free, and plans to share on a podcast all the cancer-related information that she learned throughout the ordeal.
“I have SO much information and SO many breakthroughs that I think/hope can save others. I do plan to share everything on my podcast and on as many platforms as I can. For now I'll say how grateful I am to be able alive and well and that I WILL get to hold my baby!” she said on Instagram.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
FDA Approves Onivyde as First-Line Treatment of Metastatic Pancreatic Cancer
February 13th 2024The Food and Drug Administration has approved Onivyde with oxaliplatin, fluorouracil and leucovorin, for the first-line treatment of patients with metastatic pancreatic adenocarcinoma, the agency has announced.
Read More
Ativan Associated With Worse Survival For Patients With Pancreatic Cancer
August 31st 2023Researchers found that patients with pancreatic cancer receiving chemotherapy saw worse survival outcomes when taking Ativan, commonly prescribed to treat anxiety. What other mental health options are available?
Read More